TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | 3 | 0 | -5 | -22 | -36 | -27 | -17 |
| S | %wins | 50 | 50 | 50 | 50 | 100 | 50 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/30/04 16:10 | 11/29/04 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Stinchcomb Dan T | CO | O | Exec. VP | S.dm | -43 | 1.10 | 0 | -39 | -86 | 6 | D | 188 | -65 | -24 | -23 | -25 | -26 | -11 | 1 | 7 | 2 | 13 | 7 | -26 | 9 |
11/30/04 16:10 | 11/30/04 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Stinchcomb Dan T | CO | O | Exec. VP | M.d | 7 | 0.3400 | 0 | 19 | 6 | D | 188 | -65 | -24 | -23 | -25 | -26 | -11 | 1 | 7 | 2 | 13 | 7 | -26 | 9 | |
3/1/04 15:09 | 2/27/04 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Stinchcomb Dan T | CO | O | Exec. VP | M.d | 2 | 0.3400 | 0 | 6 | 28 | 26 | D | 159 | 270 | 95 | -14 | 2 | 12 | 12 | 17 | -2 | -2 | -23 | -50 | -46 | -63 |
3/1/04 15:09 | 2/27/04 | HSKA | Heska Corp | DE | Health | BioPrd | Biological Products, (No Diag | Stinchcomb Dan T | CO | O | Exec. VP | S.d | -2 | 2.34 | 0 | -1 | -3 | 26 | D | 159 | 270 | 95 | -14 | 2 | 12 | 12 | 17 | -2 | -2 | -23 | -50 | -46 | -63 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |